Law firms Dealwatch: Baker & McKenzie and Ropes & Gray lead on Merck’s $8.4bn superbug takeover Legal Business · 9 December 2014 · 2 min read Corporate and M&A Deal watch US firms Baker McKenzie Ropes & Gray One of the world’s biggest pharma groups, New Jersey-based Merck, instructed an all-female partner team from Baker & McKenzie to help it execute its $8.4bn takeover of Cubist Pharmaceuticals.Your limit of 1 article in 30 days is up. Please login for full access or subscribe. Corporate users - click here for simple access (no password needed). For more information, please contact [email protected] Related ContentMore in this categoryPrivate equity hires in London nearly double in 2025, new findings showLaw firmsKate Peacock21 Apr 2026Revolving Doors: Weil hires Kirkland secondaries partner as Orrick targets Cadwalader againLaw firmsKate Peacock14 Apr 2026Ropes & Gray adds new private equity partner as Milan office growsLaw firmsWill Lewallen13 Apr 2026How CMS M&A partner David Roberts became the restaurant expert on both sides of the tableLaw firmsKate Peacock20 Apr 2026‘We’ve got the building blocks in place to grow’ – Harbottle closes in on £60mLaw firmsTom Cox17 Apr 2026Hogan Lovells and Cadwalader partners approve largest ever law firm mergerLaw firmsKate Peacock15 Apr 2026‘There’s a lot of money in Chicago’ – the city’s top lawyers on what’s driving business in the MidwestLaw firmsAlex Ryan13 Jan 2025Legal 500 US: Latham tops the charts in new US rankingsLegal 500 dataBarnaby Merrill28 Jun 2024Dealwatch: Global 100 advisers take centre stage on BlackRock-GIP $12.5bn mega dealLaw firmsAlex Ryan15 Jan 2024